Skip to main content

InspireMD, Inc.

NSPR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001433607

In the last 90 days, InspireMD, Inc. insiders filed 5 open-market purchases and 0 sales; 38 institutions reported holding it in 13F filings for Q3 2026, worth $14.6M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 18, 2026
$37.1M
Insider buysLast 90 days, $455.0K in total
5
Insider sellsOpen market, last 90 days
0
13F holdersQ3 2026, +2 vs. previous quarter
38
13F valueReported value at the end of Q3 2026
$14.6M
Superinvestors holdingAt the end of Q3 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
$8.98M
+28.1% year over year
Net income, FY2025
-$48.8M
No comparable prior period
Free cash flow, FY2025
-$36.8M
No comparable prior period
Revenue, Q3 FY2026
$2.24M
−11.1% year over year

Revenue flow, FY2025

Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.

Net loss for FY2025: $48.8M (543.3% of revenue).

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
251.5K
Shares sold short
Change
+170.6K
+210.9% vs. previous
Days to cover
1.00
At average daily volume

Superinvestors holding NSPR, Q3 2026

Go to the superinvestors tab

No superinvestor reported holding NSPR at the end of Q3 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by InspireMD, Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 17, 2026 (view filing)4:05 PM ETNov 134 daysStuka PaulDirectorPPurchase+307.7K$0.65+$200.0K+72.6%731.4K after
Nov 17, 2026 (view filing)4:05 PM ETNov 134 daysStuka PaulDirectorPPurchase+230.8K$0.00$0–230.8K afterDerivative
Nov 17, 2026 (view filing)4:05 PM ETNov 134 daysLawless Michael AChief Financial OfficerPPurchase+115.4K$0.65+$75.0K+16.7%807.1K after
Nov 17, 2026 (view filing)4:05 PM ETNov 134 daysLawless Michael AChief Financial OfficerPPurchase+86.5K$0.00$0–86.5K afterDerivative
Nov 17, 2026 (view filing)4:05 PM ETNov 134 daysBerman MichaelDirectorPPurchase+76.9K$0.65+$50.0K+21.8%429.5K after
Nov 17, 2026 (view filing)4:05 PM ETNov 134 daysBerman MichaelDirectorPPurchase+57.7K$0.00$0–57.7K afterDerivative
Nov 17, 2026 (view filing)4:05 PM ETNov 134 daysSlosman MarvinCEO and PresidentPPurchase+46.2K$0.65+$30.0K+1.3%3.60M after
Nov 17, 2026 (view filing)4:05 PM ETNov 134 daysSlosman MarvinCEO and PresidentPPurchase+34.6K$0.00$0–34.6K afterDerivative
Nov 17, 2026 (view filing)4:05 PM ETNov 134 daysRoubin Gary SDirectorPPurchase+153.8K$0.65+$100.0K+18.4%988.3K after
Nov 17, 2026 (view filing)4:05 PM ETNov 134 daysRoubin Gary SDirectorPPurchase+115.4K$0.00$0–115.4K afterDerivative

Top 10 13F holders, Q3 2026

See all 38 holders

The largest institutional positions in InspireMD, Inc. at the end of Q3 2026; share changes are against Q2 2026.

Institutions holding NSPR in Q3 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Rosalind Advisors, Inc.3,905,743$2.62M0.85%00.0%Unchanged
Standard Life Aberdeen plc3,698,364$2.48M0.00%00.0%Unchanged
Nantahala Capital Management, LLC3,376,484$2.25M0.13%00.0%Unchanged
OrbiMed Advisors LLC3,133,405$2.09M0.04%00.0%Unchanged
Parkman Healthcare Partners LLC2,416,518$1.61M0.15%00.0%Unchanged
Marshall Wace, LLP1,860,405$1.25M0.00%00.0%Unchanged
Soleus Capital Management, L.P.1,045,708$698.3K0.02%00.0%Unchanged
Velan Capital Investment Management LP924,680$617.5K0.59%+776,542+524.2%Added
Ingalls & Snyder LLC362,550$242.0K0.01%−6,250−1.7%Reduced
Affiance Financial, LLC250,370$167.2K0.02%00.0%Unchanged

Holders of 5% or more of NSPR

See all 9 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of InspireMD, Inc..

Largest holders of NSPR from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Marshall Wace, LLP13G/A9.99%28.1M shares–Nov 14, 20251 filingNov 14, 2025SEC
Nantahala Capital Management, LLC13G/A9.99%4.82M shares0.00 ppfrom 9.99%Feb 14, 20246 filingsMay 15, 2026SEC
Rosalind Advisors, Inc.13G/A9.20%11.0M shares−0.70 ppfrom 9.90%Jun 8, 202312 filingsFeb 11, 2026SEC
Lawless Michael A13D8.60%3.61M sharesNewOct 29, 20251 filingOct 29, 2025SEC
Standard Life Aberdeen plc13G/A7.49%3.17M shares+1.54 ppfrom 5.95%Nov 7, 20252 filingsFeb 2, 2026SEC